Dispersal policy for people with
HIV was changed in response to evidence of the adverse effects of rapid
dispersal on HIV-positive asylum seekers. A survey of doctors in genitourinary
clinics in England
found problems of treatment interruption, with examples of deaths and mother-to-child
transmission attributable to dispersal.1 It found that patients were dispersed against medical
advice and at very short notice, and recommended improved arrangements for
onward transfer of medical information.
Following the independent 'Scott review' of the healthcare needs of
people seeking asylum generally, the National AIDS Trust (NAT) and the British
HIV Association (BHIVA) surveyed HIV clinicians to better understand the
experience of treating HIV-positive asylum seekers during dispersal. The
survey found inadequate notice periods to prepare patients for dispersal,
leading to interruptions in medication and poor handover of medical
details.
As a result, NAT and BHIVA worked with NASS to ensure its policy
on dispersal and healthcare needs appropriately considered HIV-related
needs during the dispersal process. There are a number of detailed
instructions relating to the safe and appropriate dispersal of newly arrived
asylum seekers with HIV in the resulting UKBA's Asylum Support Policy Bulletin
85, Dispersing Asylum Seekers with Healthcare
Needs.2
In order for UKBA to take proper
account of HIV in dispersal, HIV-positive asylum seekers in initial
accommodation need to disclose their status.2,3 HIV testing should also be offered at this stage if
requested or clinically advised.
Planning for dispersal requires information
about health conditions so that appropriate steps can be taken to enable
treatment to be started or continued without interruption. It is therefore
important that applications for support (known as the NASS 1 form) include information
about medical reasons for requesting dispersal to a particular area, or to
remain in the same area, and about treatment needs.
UKBA has recognised that many
people with HIV are fearful of disclosing their status. Staff are, therefore,
instructed to explain to asylum seekers that neither requesting an HIV test nor
disclosing HIV-positive status will adversely affect their asylum claim, and
that support applications are treated quite separately from asylum
applications, and with complete confidentiality.4 This assurance is the responsibility not only of
healthcare staff, but also of staff assisting with applications for support.
Asylum seekers living in the community who receive only one day's induction
will have less opportunity to obtain such reassurance, or to get other
information about HIV.5
UKBA policy states that newly
arrived asylum seekers with HIV/AIDS who are not currently receiving ongoing
treatment in the UK
should be dispersed from initial accommodation as soon as possible in order to
enable them to start treatment in the dispersal area. In other cases, dispersal
of asylum seekers living with HIV should only take place after expert advice is
received from the treating doctor. This will include advice about the
availability of treatment in potential dispersal locations. Dispersal in the
same area as the initial accommodation may be possible in order to minimise
upheaval and to avoid delays.6
Dispersal should also not take
place until the asylum seeker and the current doctor have had time to prepare
adequately for dispersal, and arrangements have been confirmed with the UKBA or
the medical adviser at the initial accommodation. It should normally only take
place if the asylum seeker is medically stable and has no other health
complications. Such arrangements are expected to be completed within 4 to 6
weeks.7
The arrangements that need to be
in place before dispersal of an HIV-positive asylum seeker include a
requirement that the treating clinician is informed of the new address and is
satisfied that the accommodation being provided is suitable, and that other
facilities are in place to ensure continuity of care. The current doctor must
be ready to discharge the patient and transfer his or her treatment to the new primary care trust. They must also advise on the asylum seeker's fitness to
travel and provide them with sufficient medication to last until the new doctor
has an opportunity to review the current treatment regime.
BHIVA and NAT have produced
further advice on the dispersal process for health and voluntary sector
professionals working with HIV-positive asylum seekers. This details the
information which should be given to the UKBA caseworker to inform
decision-making about the appropriateness and type of dispersal for each
person.8
In the case of HIV-positive
women who are pregnant, the UKBA policy notes that additional care is required
and instructs that the case be transferred to the Complex Casework Team.8 There are already special
guidelines for the dispersal of pregnant women from initial accommodation, but
it is a requirement that doctors confirm a woman's HIV status in writing if
specialist treatment is required so that other arrangements can be made.9
Where there are families with
children living with HIV, the guidelines state that extra care should be taken
in finding accommodation that is located where there are appropriate facilities
for treating children with HIV. Clinicians' advice should be sought on
identifying specialist centres with facilities for family care.10
In both these cases the
BHIVA/NAT guidance advocates that health and voluntary sector professionals
seek to secure a delay in dispersal if the caseworker for the pregnant woman or
child has not previously made contact.
Although delaying dispersal
where necessary in order to ensure continuity of care and adequate
accommodation in the dispersal area is advised by both HIV advocacy
organisations and the UKBA guidelines, there will be a consequent delay in the
asylum seeker receiving section 95 support. During this time, the asylum seeker
will have no cash for basic needs such as travel or any additional food other
than what is provided in the initial accommodation. This could be harmful for a
person on antiretroviral medication.11
The accommodation providers in
the dispersal areas have responsibilities to ensure that asylum seekers with
pre-existing health conditions (including HIV) are registered with a general
practitioner (GP) as soon as they arrive.12,13 Case workers should inform the accommodation provider
that the person has a pre-existing medical condition without specifying the
actual illness.14
The
providers are also required to provide accommodation suitable for the needs of
a person with a medical condition in response to requests from the medical
adviser at the initial accommodation. In the case of a person living with
HIV/AIDS, this might include the need for an individual rather than a shared
bathroom, for the sole use of a refrigerator, or for damp or draught-free
living conditions, as well as to be situated in an area where particular
services are available.
BHIVA/NAT guidance provides
detailed recommendations as to the procedures which should be followed by both
current and 'receiving' clinicians and GPs in the event of the dispersal of a
person living with HIV in order to ensure continuity of care. The guidance also
suggests that voluntary sector (HIV or asylum) organisations with which HIV-positive
asylum seekers are in contact should provide their clients with information
about similar organisations in the receiving areas.
The guidance advocates that
clinicians encourage their patients to let them know immediately if they
receive a dispersal notice so that appropriate planning and arrangements can be
made. If asylum seekers are moved a second time, after having been dispersed,
similar criteria and procedures for safe and appropriate dispersal should be
applied.
The effect of the revised policy
has been to disperse people with HIV to areas where treatment is available and
so it has become more difficult to challenge dispersal decisions, even if
someone is very ill, unless there are other considerations such as significant
mental-health needs or serious disruption to the welfare of children.
In the
past, many people with HIV were able to stay in a particular area to continue
treatment by requesting a community-care assessment and support from social
services under section 21 of the National
Assistance Act 1948. Since the House of Lords judgment in M. v. Slough Borough Council,
many HIV-positive asylum seekers are no longer able to receive housing and
support from social services under Section 21 of the National Assistance Act.
For asylum seekers, this
means that if their support needs involve only accommodation and medication,
they will have to be supported by UKBA, and thus are likely to be dispersed.
This judgment has implications for people living with HIV who wish to challenge
dispersal, as well as for refused asylum seekers who receive Section 4 support from
the UKBA which almost always involves dispersal from London or south-east
England.